Search for " " - Xconomy

Results for “ ”

Entry	Author	Date	Location
FDA Again Halts Solid Bio’s Duchenne Gene Therapy Clinical Trial	Frank Vinluan	11/12/19	Boston
Roche Challenger to Biogen’s SMA Drug Succeeds in Pivotal Study	Frank Vinluan	11/11/19	National
Neuroscience Is Taking the Spotlight at Xconomy’s Bay Area Xchange	Frank Vinluan	11/11/19	San Francisco
Anemia Drug From Acceleron Pharma and Celgene Wins FDA Approval	Frank Vinluan	11/08/19	New York
Bio Roundup: Feds Sue Gilead, Biogen Eyes China, CRISPR’d Kidneys & More	Frank Vinluan	11/08/19	National
eGenesis Lands $100M to Advance CRISPR-ed Pig Kidney to Human Test	Frank Vinluan	11/07/19	Boston
Arkuda Unveils $44M and a Protein Restoration Approach to Dementia	Frank Vinluan	11/07/19	Boston
3 Changes We Should Make to Address the Gender Pay Gap in Medicine	Alex Harding	11/06/19	Boston
AstraZeneca Chooses China for R&D and AI Centers, $1B Biotech Fund	Gareth Macdonald	11/06/19	National
Biogen Adds Two More Biosimilars in $100M Deal with Samsung Bioepis	Frank Vinluan	11/06/19	Boston
GE Healthcare Opens Startup Labs at Former AstraZeneca UK R&D Site	Dan Stanton	11/06/19	National
Why Steve Kafka Left Third Rock Ventures for Up-and-Comer Section 32	Sarah de Crescenzo	11/05/19	San Diego
Biotech Roundup: Novartis on Hold, AMAG Vote, Neuro News & More	Frank Vinluan	11/01/19	National
Pinteon Gets $17M to Tackle Tau in Alzheimer’s, Other Brain Diseases	Frank Vinluan	10/31/19	Boston
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug	Frank Vinluan	10/31/19	Boston
FDA Halts Novartis Gene Therapy Study Amid Animal Safety Concerns	Frank Vinluan	10/30/19	National
Disc Medicine Launches With $50M to Advance New Anemia Treatments	Sarah de Crescenzo	10/29/19	Boston
Bio Roundup: Biogen’s Reversal, FDA Moves Fast, a CF Cocktail & More	Sarah de Crescenzo	10/25/19	National
Former Quartet, Knewton Exec David Liu Joins Sonde Health as CEO	Frank Vinluan	10/24/19	Boston
Xconomy Awards Boston 2019 Honors Best in Life Sciences: Slideshow	Jeff Bauter Engel	10/23/19	Boston
Biogen Reverses Course on Alzheimer’s Drug Analysis, Plans FDA Filing	Sarah de Crescenzo	10/22/19	Boston
Vertex Stock Up on Quick FDA OK For 3-Drug Cystic Fibrosis Therapy	Sarah de Crescenzo	10/22/19	Boston
Backed by $50M, Verseau Launches to Reprogram Immune Cells Against Cancer	Frank Vinluan	10/21/19	Boston
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More	Frank Vinluan	10/18/19	National
Healx Bags $56M to Advance Affordable, AI-Based Orphan Drugs	Mike Ward	10/17/19	National
Nuance & Microsoft Team Up on Conversational AI for Doctors’ Offices	Jeff Bauter Engel	10/17/19	Boston
ArsenalBio Launches With $85M for “Programmable” T Cell Therapies	Frank Vinluan	10/17/19	San Francisco
Alexion to Buy Achillion in $930M Marriage of Rare Disease Drug Firms	Frank Vinluan	10/16/19	Boston
Cyteir Adds $40M for Clinical Test of “Synthetically Lethal” Cancer Drug	Frank Vinluan	10/15/19	Boston
FDA OKs Lilly’s Lasmiditan, First New Acute Migraine Drug in Decades	Frank Vinluan	10/11/19	Indiana
Page 1 of 626	next page »